Author:
Braathen Ranveig,Spång Heidi Cecilie Larsen,Hinke Daniëla Maria,Blazevski Jana,Bobic Sonja,Fossum Even,Bogen Bjarne
Funder
Research Council of Norway
NanoCanTher
Inno Indigo
South-Eastern Norway Regional Health Authority, Norway,
K.G. Jebsen Centre for Influenza Vaccine Research, Norway
Norwegian Cancer Society, Norway,
Subject
Genetics,Molecular Biology,Molecular Medicine
Reference43 articles.
1. West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays;Davis;J. Virol.,2001
2. Long-term survival of dogs with advanced malignant melanoma after DNA vaccination with xenogeneic human tyrosinase: a phase I trial;Bergman;Clin. Cancer Res.,2003
3. The road to licensure of a DNA vaccine;Salonius;Curr. Opin. Investig. Drugs,2007
4. Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial;Trimble;Lancet,2015
5. DNA vaccines, electroporation and their applications in cancer treatment;Lee;Hum. Vaccin. Immunother.,2015
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献